IQVIA Holdings Inc.
IQV
株式のランク
#557
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
株価
$267.50
最終同期: 2026-10-20
時価総額
$44.03B
変化（1日）
0.62%
変化（1年）
22.33%
国
US
取引 IQVIA Holdings Inc. (IQV)
カテゴリー
Healthcare
IQVIA Holdings Inc.（IQV）のP/E比率
October 2026 時点のP/E比率 TTM 32.24
IQVIA Holdings Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は 32.24 です。2024 年末時点での P/E は 25.95 でした。
IQVIA Holdings Inc. の P/E 比率の履歴（2010 〜 2026）
各年末のP/E比率
| 年 | P/E比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 32.24 | 13.18% |
| 2025 | 28.49 | 9.80% |
| 2024 | 25.95 | -17.14% |
| 2023 | 31.32 | -11.11% |
| 2022 | 35.23 | -36.98% |
| 2021 | 55.90 | -54.50% |
| 2020 | 122.85 | -22.16% |
| 2019 | 157.83 | 72.74% |
| 2018 | 91.37 | 460.90% |
| 2017 | 16.29 | -83.48% |
| 2016 | 98.60 | 351.94% |
| 2015 | 21.82 | 3.19% |
| 2014 | 21.14 | -16.72% |
| 2013 | 25.39 | -14.68% |
| 2012 | 29.76 | 36.17% |
| 2011 | 21.85 | -33.58% |
| 2010 | 32.90 | 0.00% |
類似企業や競合他社のP/E比率
| 企業 | P/E比率 | P/E比率の差 | 国 |
|---|---|---|---|
| 36.15 | 12.13% |
US
|
|
| 39.77 | 23.35% |
US
|
|
| -290.26 | -1,000.17% |
US
|
|
| - | - |
CN
|
|
| 34.18 | 6.02% |
US
|
P/E比率の読み方
株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。
P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。
10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。